灭活脊髓灰质炎·狂犬病(恐水症)疫苗市场:疫苗，各灭活方法，各年龄层，各流通管道，各地区- 市场规模，占有率，展望，机会分析，2023年～2030年

市场动态

市场参与者的研发活动预计将在预测期内刺激全球灭活脊髓灰质炎和狂犬病疫苗市场的增长。例如，2021 年 3 月，美国生物技术公司 Ocugen Inc. 公布了积极的营收数据用于狂犬病、脊髓灰质炎和COVID-19疫苗。研究性疫苗使用数十年来用于生产脊髓灰质炎疫苗的相同 vero 细胞製造平台。

本调查的主要特征

• 本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球灭活脊髓灰质炎·狂犬病(恐水症)疫苗市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
• 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
• 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
• 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球灭活脊髓灰质炎·狂犬病(恐水症)疫苗市场的主要参与者之企业简介。
• 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 全球灭活脊髓灰质炎·狂犬病(恐水症)疫苗市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以透过全球灭活脊髓灰质炎·狂犬病(恐水症)疫苗市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

• 调查目的
• 前提条件
• 简称

第2章 市场概况

• 报告概要
  • 市场定义和范围
• 摘要整理
• 连贯·机遇·地图(COM)

第3章 市场动态，法规，趋势分析

• 市场动态
  • 促进因素
  • 阻碍因素
  • 市场机会
  • 影响分析
  • 最近的产品上市
  • 流行病学
  • 合併，收购，联盟
  • 法规情势
  • 主要的发展
  • PEST分析

第4章 灭活脊髓灰质炎·狂犬病(恐水症)疫苗的全球市场-冠状病毒(COVID-19)大流行病的影响

• 经济影响
• COVID-19流行病学
• 需求与供给的影响

第5章 灭活脊髓灰质炎·狂犬病(恐水症)疫苗的全球市场:各产品类型，2018年～2030年

• 灭活小儿麻庳疫苗简介
• 灭活狂犬病(恐水症)疫苗的简介

第6章 灭活脊髓灰质炎·狂犬病(恐水症)疫苗的全球市场:各灭活方法，2018年～2030年

• 溶剂清洗法
• 放射线法
• pH浓度
• 加热灭活
• 其他

第7章 灭活脊髓灰质炎·狂犬病(恐水症)疫苗的全球市场:各年龄层，2018年～2030年

• 小儿科
• 成人

第8章 灭活脊髓灰质炎·狂犬病(恐水症)疫苗的全球市场:各流通管道，2018年～2030年

• 政府机关
• 民间

第9章 灭活脊髓灰质炎·狂犬病(恐水症)疫苗的全球市场:各地区，2018年～2030年

• 北美
• 美国
• 加拿大
• 欧洲
• 英国
• 德国
• 义大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲
• 亚太地区
• 中国
• 印度
• 日本
• ASEAN
• 澳洲
• 韩国
• 其他亚太地区
• 南美
• 巴西
• 墨西哥
• 阿根廷
• 其他南美国家
• 中东
• GCC
• 以色列
• 其他中东
• 非洲
• 北非
• 中非
• 南非

第10章 企业简介

• Bharat Biotech
  • 公司概要
  • 产品系列
  • 业绩
  • 最近的开发/最新资讯
  • 策略
• BIO-MED
• Serum Institute of India Pvt. Ltd.
• Kedrion Biopharma Inc.
• GlaxoSmithKline plc.
• Bilthoven Biologicals
• Merck & Co., Inc.
• Pfizer Inc.
• Cadila Healthcare Limited
• Sanofi Pasteur India Pvt Ltd
• Chiron Behring Vaccines Private Ltd
• Zoetis Inc.
• Elanco.
• Boehringer Ingelheim International GmbH
• Indian Immunologicals Ltd
• Wyeth pharmaceuticals
• Berna Biotech Ltd.
• Novartis Vaccines Ltd
• Medimmune LLC

第11章 章节

• 参考文献
• 调查手法

A vaccine consisting of inactivated poliovirus (IPV) types 1, 2, and 3, with active immunizing activity against poliomyelitis. Upon intramuscular vaccination, inactivated poliovirus vaccine (IPV) activates the immune system to develop antibodies against polio viruses. The rabies vaccine is a vaccine used to prevent rabies. There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies before, and, for some time, after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite. Governments around the world are actively working towards eradicating polio, which has led to increased demand for IPV. Additionally, the rising prevalence of polio in certain regions, such as the North America region, has also contributed to the growth of this segment. The increasing prevalence of polio and rabies diseases is driving the growth of the inactivated polio and the rabies vaccine associated with the virus is expected to boost the global inactivated polio and rabies vaccine market growth.

Market Dynamics

Research and development activity by market players is expected to spur the global inactivated polio and rabies vaccines market growth over the forecast period. For Instance, in March 2021, Ocugen Inc., is a biotech company in the U.S., announced positive top-line data for rabies, polio and COVID-19 Vaccine. Investigational vaccine that uses the same vero cell manufacturing platform that had been used in the production of polio vaccines for decades.

Key features of the study:

• This report provides an in-depth analysis of the global inactivated polio and rabies vaccines market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global inactivated polio and rabies vaccines market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bharat Biotech., BIO-MED, Serum Institute of India Pvt. Ltd., Kedrion Biopharma Inc. GlaxoSmithKline plc., Bilthoven Biologicals, Merck & Co., Inc., Pfizer Inc, Cadila Healthcare Limited, Sanofi Pasteur India Pvt Ltd, Chiron Behring Vaccines Private Ltd ,Zoetis Inc., Elanco.,Boehringer Ingelheim International GmbH,Indian Immunologicals Ltd, Wyeth pharmaceuticals, Berna Biotech Ltd., Novartis Vaccines Ltd and Medimmune LLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global inactivated polio and rabies vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Inactivated Polio And Rabies Vaccines Market

Detailed Segmentation:

• Global Inactivated Polio And Rabies Vaccines Market, By Product Type:
  • Inactivated Polio Vaccine
  • Inactivated Rabies Vaccine
• Global Inactivated Polio And Rabies Vaccines Market, By Method of Inactivation:
  • Radiation Method
  • Heat Inactivation
  • Solvent Detergent Method
  • pH Concentration
  • Health Activation
  • Others
• Global Inactivated Polio And Rabies Vaccines Market, By Age Group:
  • Pediatrics
  • Adults
• Global Inactivated Polio And Rabies Vaccines Market, By Distribution Channel:
  • Government
  • Private
• Global Inactivated Polio And Rabies Vaccines Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Bharat Biotech.Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BIO-MED
  • Serum Institute of India Pvt. Ltd.
  • Kedrion Biopharma Inc.
  • GlaxoSmithKline plc..
  • Bilthoven Biologicals.
  • Merck & Co.
  • Pfizer Inc.
  • Cadila Healthcare Limited
  • Sanofi Pasteur India Pvt Ltd
  • Chiron Behring Vaccines Private Ltd
  • Zoetis Inc.
  • Boehringer Ingelheim International GmbH
  • Indian Immunologicals Ltd
  • Wyeth pharmaceuticals
  • Berna Biotech Ltd.
  • Novartis Vaccines Ltd
  • Medimmune LLC.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product type
  • Market Snapshot, By Method of Activation
  • Market Snapshot, By Age Group
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaboration
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Inactivated Polio and Rabies Vaccines Market- Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Inactivated Polio and Rabies Vaccines Market, By Product Type, 2018 - 2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Inactivated Polio Vaccine Introduction
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
• Inactivated Rabies Vaccine Introduction
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

6. Global Inactivated Polio and Rabies Vaccines Market, By Method of Inactivation, 2018 - 2030 (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Solvent Detergent Method
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
• Radiation Method
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
• pH Concentration
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
• Heat Inactivation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)

7. Global Inactivated Polio and Rabies Vaccines Market, By Age Group, 2018 - 2030 (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Pediatrics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)

8. Global Inactivated Polio and Rabies Vaccines Market, By Distribution Channel, 2018 - 2030 (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Government
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
• Private
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)

9. Global Inactivated Polio and Rabies Market, By Region, 2018 - 2030 (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
• North America
  • Market Size and Forecast, By Vaccine, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Method of Inactivation, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2018 - 2030 (US$ Mn)
• U.S.
• Canada
• Europe
  • Market Size and Forecast, By Vaccine, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Method of Inactivation, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2018 - 2030 (US$ Mn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Vaccine, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Method of inactivation, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2018 - 2030 (US$ Mn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Market Size and Forecast, By Vaccine, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Method of inactivation, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2018 - 2030 (US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Market Size and Forecast, By Vaccine, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Method of inactivation, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2018 - 2030 (US$ Mn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Market Size and Forecast, By Vaccine, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Method of inactivation, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2018 - 2030 (US$ Mn)
• North Africa
• Central Africa
• South Africa

10. Company Profiles

• Bharat Biotech
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
• BIO-MED
• Serum Institute of India Pvt. Ltd.
• Kedrion Biopharma Inc.
• GlaxoSmithKline plc.
• Bilthoven Biologicals
• Merck & Co., Inc.
• Pfizer Inc.
• Cadila Healthcare Limited
• Sanofi Pasteur India Pvt Ltd
• Chiron Behring Vaccines Private Ltd
• Zoetis Inc.
• Elanco.
• Boehringer Ingelheim International GmbH
• Indian Immunologicals Ltd
• Wyeth pharmaceuticals
• Berna Biotech Ltd.
• Novartis Vaccines Ltd
• Medimmune LLC

11. Section

• References
• Research Methodology
• About us and Sales Contact

Browse 36 market data tables and 32 figures on "Global Inactivated Polio And Rabies Vaccines Market " - Global Forecast to 2030